HKG:6821 Market Cap

HKG:6821 has a market cap or net worth of 37.85 billion as of October 31, 2025. Its market cap has increased by 29.74% in one year.

Market Cap

37.85B

Enterprise Value

29.60B

Revenue

6.88B

Ranking

n/a

PE Ratio

33.34

Stock Price

83.70

Market Cap Chart

Since November 18, 2016, HKG:6821's market cap has increased from 5.59B to 37.85B, an increase of 577.01%. That is a compound annual growth rate of 23.81%.

Market Cap History

Date	Market Cap	% Change
Oct 30, 2025	39.52B	41.52%
Dec 31, 2024	27.92B	-38.76%
Dec 29, 2023	45.59B	-23.48%
Dec 30, 2022	59.58B	-56.36%
Dec 31, 2021	136.53B	58.47%
Dec 31, 2020	86.15B	157.03%
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Nov 18, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
BeOne Medicines AG	263.63B
Hansoh Pharmaceutical Group Company	207.05B
JD Health International	194.33B
WuXi Biologics	148.69B
Innovent Biologics	138.28B
Sino Biopharmaceutical	122.81B
Akeso	102.15B
Sichuan Kelun-Biotech Biopharmaceutical	98.31B

Market Cap Rankings